Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 8
Submit an article Journal homepage
6,201
Views
6
CrossRef citations to date
0
Altmetric
Original Research

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

Iris KoopmansUniversity of Groningen, University Medical Center Groningen (UMCG), Department of Surgery, Laboratory for Translational Surgical Oncology, Groningen, The NetherlandsView further author information
,
Djoke HendriksUniversity of Groningen, University Medical Center Groningen (UMCG), Department of Surgery, Laboratory for Translational Surgical Oncology, Groningen, The NetherlandsView further author information
,
Douwe F. SamploniusUniversity of Groningen, University Medical Center Groningen (UMCG), Department of Surgery, Laboratory for Translational Surgical Oncology, Groningen, The NetherlandsView further author information
,
Robert J. van GinkelUniversity of Groningen, University Medical Center Groningen (UMCG), Department of Surgery, Laboratory for Translational Surgical Oncology, Groningen, The NetherlandsView further author information
,
Sandra HeskampRadboud University Medical Center, Department of Radiology and Nuclear Medicine, Nijmegen, The NetherlandsView further author information
,
Peter J. WierstraRadboud University Medical Center, Department of Radiology and Nuclear Medicine, Nijmegen, The NetherlandsView further author information
,
Edwin BremerUniversity of Groningen, UMCG, Department of Hematology, Section Immunohematology, Groningen, The NetherlandsView further author information
&
Wijnand HelfrichUniversity of Groningen, University Medical Center Groningen (UMCG), Department of Surgery, Laboratory for Translational Surgical Oncology, Groningen, The NetherlandsCorrespondence[email protected]
View further author information
 show all
Article: e1466016 | Received 24 Jan 2018, Accepted 11 Apr 2018, Published online: 31 May 2018

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Laura Rubio-Pérez, Rodrigo Lázaro-Gorines, Seandean L. Harwood, Marta Compte, Rocío Navarro, Antonio Tapia-Galisteo, Jaume Bonet, Belén Blanco, Simon Lykkemark, Ángel Ramírez-Fernández, Mariola Ferreras-Gutiérrez, Carmen Domínguez-Alonso, Laura Díez-Alonso, Alejandro Segura-Tudela, Oana Hangiu, Ainhoa Erce-Llamazares, Francisco J. Blanco, Cruz Santos, José L. Rodríguez-Peralto, Laura Sanz & Luis Álvarez-Vallina. (2023) A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. OncoImmunology 12:1.
Read now
Cong-Li Jia, Fu Yang & Rui-Ning Li. (2022) Identification of Potential Core Genes Between Primary and Metastatic Malignant Melanoma and Analysis of Their Immune Correlation. International Journal of General Medicine 15, pages 379-391.
Read now
Jorge Cebada, Amira Flores, Cindy Bandala, Ian Lizaliturri-Flores, Nemesio Villa-Ruano & Martin Perez-Santos. (2020) Bispecific anti-PD-1/LAG-3 antibodies for treatment of advanced or metastatic solid tumors: a patent evaluation of US2018326054. Expert Opinion on Therapeutic Patents 30:7, pages 487-494.
Read now
Mark A. J. M. Hendriks, Emily M. Ploeg, Iris Koopmans, Isabel Britsch, Xiurong Ke, Douwe F. Samplonius & Wijnand Helfrich. (2020) Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation. OncoImmunology 9:1.
Read now
Martin Perez-Santos, Maricruz Anaya-Ruiz, Irma Herrera-Camacho, Lourdes Millán-Pérez Peña & Nora Hilda Rosas-Murrieta. (2019) Bispecific anti-OX40/CTLA-4 antibodies for advanced solid tumors: a patent evaluation of WO2018202649. Expert Opinion on Therapeutic Patents 29:12, pages 921-924.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.